Literature DB >> 15005239

The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin.

Alessandro Peri1, Lorella Bonaccorsi, Federica Cioppi, Monica Muratori, Michaela Luconi, Simone Granchi, Mario Maggi, Elisabetta Baldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15005239     DOI： 10.1111/j.1749-0774.2003.tb00139.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN： 0914-7470            Impact factor:   4.174


× No keyword cloud information.
  21 in total

Review 1.  Biosynthesis of platelet-activating factor and enzyme inhibitors.

Authors:  F Snyder; V Fitzgerald; M L Blank
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

2.  Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells.

Authors:  L Bonaccorsi; M Luconi; M Maggi; M Muratori; G Forti; M Serio; E Baldi
Journal:  Biochim Biophys Acta       Date:  1997-02-04

3.  Loss of transformed phenotype in cancer cells by overexpression of the uteroglobin gene.

Authors:  Z Zhang; G C Kundu; D Panda; A K Mandal; G Mantile-Selvaggi; A Peri; C J Yuan; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells.

Authors:  Z Honda; T Takano; Y Gotoh; E Nishida; K Ito; T Shimizu
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

5.  Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor.

Authors:  A Peri; L Bonaccorsi; M Muratori; M Luconi; E Baldi; S Granchi; A Pesciullesi; E Mini; F Cioppi; G Forti; M Serio; L Miele; M Maggi
Journal:  Int J Cancer       Date:  2000-11-15       Impact factor: 7.396

Review 6.  Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.

Authors:  Philip J S Stork; John M Schmitt
Journal:  Trends Cell Biol       Date:  2002-06       Impact factor: 20.808

Review 7.  Platelet-activating factor in human endometrium.

Authors:  E Baldi; L Bonaccorsi; G Finetti; M Luconi; M Muratori; T Susini; G Forti; M Serio; M Maggi
Journal:  J Steroid Biochem Mol Biol       Date:  1994-06       Impact factor: 4.292

8.  Loss of uteroglobin expression in prostate cancer: relationship to advancing grade.

Authors:  A T Weeraratna; J A Cajigas; A Schwartz; E G Enquist; M J Manyak; S R Patierno
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.

Authors:  M Maggi; L Bonaccorsi; G Finetti; V Carloni; M Muratori; G Laffi; G Forti; M Serio; E Baldi
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.

Authors:  G Camussi; C Tetta; F Bussolino; C Baglioni
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307
View more
  1 in total

1.  Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.

Authors:  Tej Pratap Singh; Barbara Huettner; Harald Koefeler; Gerlinde Mayer; Isabella Bambach; Katrin Wallbrecht; Michael P Schön; Peter Wolf
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.